This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$5.7M
Filings
61
Firms Hired
2
Active Period
2013–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Fort Ontario Holocaust Refugee Shelter National Historical Park Establishment Act
2026 · first_quarter · Firm: ELEKTA, INC.
ROCR, HR1031 and S.2120
Client expense: $70,000 · Firm income: —
Matched citations: HR1031
Older Americans Act Reauthorization Act of 2025
2026 · first_quarter · Firm: ELEKTA, INC.
ROCR, HR1031 and S.2120
Client expense: $70,000 · Firm income: —
Matched citations: S.2120
Fort Ontario Holocaust Refugee Shelter National Historical Park Establishment Act
2025 · third_quarter · Firm: ELEKTA, INC.
Medicare Reimbursement and general Medicaid issues ROCR, H.R.1031 and S.2021
Client expense: $70,000 · Firm income: —
Matched citations: H.R.1031
Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031 Cancer Care
Client expense: $70,000 · Firm income: —
Matched citations: H.R. 2120
Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031 Cancer Care
Client expense: $70,000 · Firm income: —
Matched citations: S. 1031
Medicare Reimbursement and general Medicaid issues ROCR, H.R.1031 and S.2021
Client expense: $70,000 · Firm income: —
Matched citations: S.2021
Fort Ontario Holocaust Refugee Shelter National Historical Park Establishment Act
2025 · fourth_quarter · Firm: ELEKTA, INC.
ROCR legislation H.R. 1031 and S. 2021 Medicare access Medicare reimbursement General Medicare issues Medicaid access Medicaid reimbursement General Medicaid issues
Client expense: $70,000 · Firm income: —
Matched citations: H.R. 1031
Close the Round-Tripping Loophole Act
2025 · fourth_quarter · Firm: ELEKTA, INC.
ROCR legislation H.R. 1031 and S. 2021 Medicare access Medicare reimbursement General Medicare issues Medicaid access Medicaid reimbursement General Medicaid issues
Client expense: $70,000 · Firm income: —
Matched citations: S. 2021
Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2120
Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031
Client expense: $30,000 · Firm income: —
Matched citations: S. 1031
Medicare Part B ROCR, S.4330/H.R. 8404
Client expense: $39,000 · Firm income: —
Matched citations: H.R. 8404
Oncology issues ROCR, S.4330/H.R.8404
Client expense: $39,000 · Firm income: —
Matched citations: H.R.8404
Oncology issues ROCR, S.4330/H.R.8404
Client expense: $39,000 · Firm income: —
Matched citations: S.4330
Medicare Part B ROCR, S.4330/H.R. 8404
Client expense: $39,000 · Firm income: —
Matched citations: S.4330
Oncology issues ROCR, S.4330/H.R.8404
Client expense: $39,000 · Firm income: —
Matched citations: H.R.8404
Medicare Part B ROCR, S.4330/H.R. 8404
Client expense: $39,000 · Firm income: —
Matched citations: H.R. 8404
Oncology issues ROCR, S.4330/H.R.8404
Client expense: $39,000 · Firm income: —
Matched citations: S.4330
Medicare Part B ROCR, S.4330/H.R. 8404
Client expense: $39,000 · Firm income: —
Matched citations: S.4330
Oncology issues ROCR, S.4330/H.R.8404
Client expense: $39,000 · Firm income: —
Matched citations: H.R.8404
Medicare Part B ROCR, S.4330/H.R. 8404
Client expense: $39,000 · Firm income: —
Matched citations: H.R. 8404
Medicare Part B ROCR, S.4330/H.R. 8404
Client expense: $39,000 · Firm income: —
Matched citations: S.4330
Oncology issues ROCR, S.4330/H.R.8404
Client expense: $39,000 · Firm income: —
Matched citations: S.4330
Further Consolidated Appropriations Act, 2020
2019 · fourth_quarter · Firm: ELEKTA, INC.
Issues pertaining to the medical device excise tax [Further Consolidated Appropriations Act, 2020 (HR 1865, Sec. 501)]
Client expense: $100,000 · Firm income: —
Matched citations: HR 1865
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
2017 · fourth_quarter · Firm: ELEKTA, INC.
Issues pertaining to the medical device excise tax; destination-based tax proposals [HR 1/PL 115-97]
Client expense: $130,000 · Firm income: —
Matched citations: HR 1
Consolidated Appropriations Act, 2016
2015 · fourth_quarter · Firm: ELEKTA, INC.
Issues related to oncology treatment products and services; Issues pertaining to the medical device excise tax [Consolidated Appropriations Act 2016 (HR 2029)]
Client expense: $160,000 · Firm income: —
Matched citations: HR 2029
Source: Senate LDA